IUPAC NAME-3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
MOLECULAR FORMULA-C17H18N2O6
MOLAR MASS-346.335 g/mol
The approved uses for are the long-term treatment of hypertension (high blood pressure) and angina pectoris. In hypertension, recent clinical guidelines generally favour diuretics and ACE inhibitors, although calcium channel antagonists, along with thiazide diuretics, are still favoured as primary treatment for over 55's and black patients.
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Formulation such as Tablets, Capsules, Liquid and semisolid Preparations and marketing of Quality Products in Domestic. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, cardiology, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. Also deals with trading o...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Distributor/Wholesaler
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 97
Total Annual Sales Volume: US$2.5 Million - US$5 Million
India
China 
